Inactive Instrument

Calendar Qiagen NV Deutsche Boerse AG

Equities

NL0000240000

End-of-day quote Deutsche Boerse AG
- EUR - Intraday chart for Qiagen NV

Chart calendar Qiagen NV

35a3bb24dff2.67ojJ62taNjIUV6jbB4NtRF0uaQxC9ZclQnTjTWqpUg.mdNsHpmZPOCQFBzrH0x4gmsn2_xhbpAo2XmMtGOSkg6z62l_458Nvv43Zg~d5b1b48f32ad6ade50fc074093b546a9

Upcoming events on Qiagen NV

2024-08-05 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-02-10 Q4 2024 Earnings Release (Projected)
2025-05-04 Q1 2025 Earnings Release (Projected)

Past events on Qiagen NV

2024-06-26 03:00 am Stifel European Healthcare Summit
2024-06-21 04:00 am Annual General Meeting
2024-06-17 12:00 pm Capital Markets Day
2024-05-22 03:00 am Deutsche Bank dbAccess European Champions Conference
2024-05-15 04:00 am Berenberg MDx Day
2024-04-30 09:00 am Q1 2024 Earnings Call
2024-04-29 04:05 pm Q1 2024 Earnings Release
2024-04-04 American Association for Cancer Research Meeting
2024-03-26 09:00 am BNP Exane Healthcare Conference
2024-03-05 02:10 pm TD Cowen Health Care Conference
2024-02-27 03:00 am UBS European Healthcare Conference
2024-02-26 03:00 am Morgan Stanley European MedTech and Life Sciences Conference
2024-02-07 09:00 am Q4 2023 Earnings Call
2024-02-06 04:05 pm Q4 2023 Earnings Release
2024-01-29 Reverse Split: 24.25 of 25
2024-01-29 Capital return instalment
2024-01-15 10:00 am German Corporate Conference
2024-01-12 03:00 am ODDO BHF Forum
2024-01-09 09:00 am Commerzbank and ODDO BHF German Investment Conference
2024-01-08 04:30 pm JPMorgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
1 526
1 526
0.06%
1 870
1 858
0.68%
2 252
2 198
2.44%
2 142
2 139
0.12%
1 965
1 960
0.26%

2 001

EBITDA
Million USD
Released
Forecast
Spread
552
532
3.7%
748
723
3.4%
884
870
1.67%
790
791
-0.14%
659
675
-2.34%

718

EBIT
Million USD
Released
Forecast
Spread
422
412
2.5%
627
623
0.57%
755
714
5.73%
656
654
0.33%
529
524
0.88%

564

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-77,8
-77,9
0.13%
439
364
20.66%
626
564
11.04%
513
538
-4.72%
430
437
-1.7%

505

Net income
Million USD
Released
Forecast
Spread
-41,5
-29,5
-40.57%
359
294
22.31%
513
475
7.83%
423
424
-0.14%
341
344
-0.65%

402

EPS
USD
Released
Forecast
Spread
-0,19
-0,11
-62.85%
1,58
1,30
20.88%
2,28
2,17
4.8%
1,90
1,96
-2.99%
1,48
1,54
-3.96%

1,81

Announcement Date04/02/2009/02/2108/02/2210/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
628
591
6.36%
516
500
3.15%
500
482
3.71%
498
486
2.55%
485
479
1.41%
495
493
0.38%
476
471
1.07%
509
504
1.01%
459
457
0.41%

495


504


534


488


523

EBITDA
Million USD
Released
Forecast
Spread
266
240
11.11%
179
165
8.14%
176
158
11.2%
169
164
2.57%
158
163
-3.31%
168
194
-13.27%
158
149
5.95%
175
175
-0.02%
153
150
1.93%

171


182


200


167


181

EBIT
Million USD
Released
Forecast
Spread
232
205
13.24%
146
133
10.33%
144
129
11.06%
135
128
5.61%
124
123
0.65%
136
134
1.4%
126
127
-0.37%
142
139
2.34%
118
117
0.49%

135


145


163


131


148

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread






95,7
94,5
1.29%

































Net income
Million USD
Released
Forecast
Spread
155
138
12.44%
96,7
78,2
23.67%
82,4
78,1
5.44%
88,8
73,7
20.58%
85,0
75,1
13.24%
80,8
86,1
-6.2%
77,8
84,7
-8.14%
97,7
92,3
5.76%
80,7
76,3
5.79%

91,8


95,7


112







EPS
USD
Released
Forecast
Spread
0,69
0,62
12.09%
0,43
0,36
21.29%
0,37
0,35
6.42%
0,40


0,38
0,33
14.04%
0,36
0,37
-2.98%
0,35
0,38
-8.76%
0,42
0,41
3.43%
0,36
0,34
6.88%

0,44


0,48


0,53


0,41


0,47

Announcement Date27/04/2226/07/2207/11/2210/02/2303/05/2308/08/2330/10/2306/02/2429/04/24-----